Business Description
ENCell Co Ltd
ISIN : KR7456070002
Share Class Description:
XKRX:456070: Ordinary SharesCompare
Compare
Traded in other countries / regions
456070.Korea IPO Date
2024-08-23Description
ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.23 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 3.96 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 13.79 | |||||
| Beneish M-Score | -3.02 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -39.3 | |||||
| 3-Year EPS without NRI Growth Rate | 48.1 | |||||
| 3-Year FCF Growth Rate | 47.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 77.56 | |||||
| 9-Day RSI | 68.25 | |||||
| 14-Day RSI | 61.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.36 | |||||
| Quick Ratio | 7.85 | |||||
| Cash Ratio | 6.81 | |||||
| Days Inventory | 58.88 | |||||
| Days Sales Outstanding | 49.21 | |||||
| Days Payable | 4.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -222.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -3.4 | |||||
| Operating Margin % | -111.68 | |||||
| Net Margin % | -48.01 | |||||
| FCF Margin % | -79.63 | |||||
| ROE % | -71.27 | |||||
| ROA % | -10.24 | |||||
| ROIC % | -19.44 | |||||
| ROC (Joel Greenblatt) % | -13.95 | |||||
| ROCE % | -28.99 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 10.91 | |||||
| PB Ratio | 3.07 | |||||
| Price-to-Tangible-Book | 2.86 | |||||
| EV-to-EBIT | -49.09 | |||||
| EV-to-EBITDA | 137.62 | |||||
| EV-to-Revenue | 14.57 | |||||
| EV-to-FCF | -14.61 | |||||
| Price-to-Net-Current-Asset-Value | 6.47 | |||||
| Price-to-Net-Cash | 8.35 | |||||
| Earnings Yield (Greenblatt) % | -2.04 | |||||
| FCF Yield % | -4.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ENCell Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 10,525.887 | ||
| EPS (TTM) (â‚©) | -818 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 61.38 | ||
| 14-Day ATR (â‚©) | 1562.913843 | ||
| 20-Day SMA (â‚©) | 15321.5 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (â‚©) | 12100 - 45800 | ||
| Shares Outstanding (Mil) | 10.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ENCell Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ENCell Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
ENCell Co Ltd Frequently Asked Questions
What is ENCell Co Ltd(XKRX:456070)'s stock price today?
The current price of XKRX:456070 is â‚©17200.00. The 52 week high of XKRX:456070 is â‚©45800.00 and 52 week low is â‚©12100.00.
When is next earnings date of ENCell Co Ltd(XKRX:456070)?
The next earnings date of ENCell Co Ltd(XKRX:456070) is .
Does ENCell Co Ltd(XKRX:456070) pay dividends? If so, how much?
ENCell Co Ltd(XKRX:456070) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers